Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | ARP-100 REF: TM-T14322CAS: 704888-90-4 | 98.24% | 37.00 €~567.00 € | Tue 18 Mar 25 |
![]() | ARP 100 REF: IN-DA00684UCAS: 704888-90-4 | 96% | 149.00 €~538.00 € | Tue 18 Mar 25 |
![]() | N-Hydroxy-2-(N-isopropoxy-[1,1'-biphenyl]-4-ylsulfonamido)acetamide REF: 10-F227599CAS: 704888-90-4 | 95.0% | To inquire | Fri 28 Mar 25 |
![]() | ARP 100 REF: TR-A774058CAS: 704888-90-4 | - - - | 5,796.00 € | Mon 28 Apr 25 |
![]() | ARP 100 REF: 3D-EDB88890CAS: 704888-90-4 | Min. 95% | - - - | Discontinued product |

ARP-100
CAS:704888-90-4
ARP-100 (MMP-2 Inhibitor III) is a potent and selective matrix metalloproteinase MMP-2 inhibitor (IC50=12 nM).
Formula:
C17H20N2O5S
Purity:
98.24%
Color and Shape:
Solid
Molecular weight:
364.42
Ref: TM-T14322
1mg | 37.00 € | ||
5mg | 70.00 € | ||
10mg | 97.00 € | ||
25mg | 188.00 € | ||
50mg | 354.00 € | ||
100mg | 567.00 € | ||
1mL*10mM (DMSO) | 77.00 € |
Estimated delivery in United States, on Tuesday 18 Mar 2025

Ref: IN-DA00684U
5mg | 149.00 € | ||
25mg | 166.00 € | ||
100mg | 469.00 € |
Estimated delivery in United States, on Tuesday 18 Mar 2025

N-Hydroxy-2-(N-isopropoxy-[1,1'-biphenyl]-4-ylsulfonamido)acetamide
CAS:704888-90-4
Purity:
95.0%
Molecular weight:
364.4200134277344
Ref: 10-F227599
250mg | To inquire |
Estimated delivery in United States, on Friday 28 Mar 2025

ARP 100
Controlled ProductCAS:704888-90-4
Formula:
C17H20N2O5S
Color and Shape:
Neat
Molecular weight:
364.416
Ref: TR-A774058
100mg | 5,796.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025

ARP 100
CAS:704888-90-4
ARP 100 is a monoclonal antibody that binds to the extracellular domain of human angiopoietin-like …
Formula:
C17H20N2O5S
Purity:
Min. 95%
Molecular weight:
364.42 g/mol
Ref: 3D-EDB88890
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information |